Introduction: Epilepsy is most common major neurological complication encounterd in pregnancy. The etiology of seizures covers a wide range of diseases, vascular insults,infectious sequelae, malignant processes and primary central nervous dysfunction. A wide range of obstetric complications have been reported including spontaneous abortion , preterm labour, stillbirth, neonatal death, hemorrhagic disease of the newborn; low apgar and low birth weight. The incidence of malformations increase from 2.9% in the non drug user group to 3.7% in patient on monotherapy and 6.6% in patients on polytherapy. Objectives: To study the maternal and perinatal outcome in pregnant women with epilepsy on polytherapy. Materials and Methods: This retrospective observational study was conducted in R.L. Jalappa Hospital Kolar India over a period of 6 months (December 2017-june2018). Five pregnant women with epilepsy attending the antenatal clinic or admitted in labour ward in a tertiary care hospital taking two or more antiepileptic drugs were evaluated. Conclusion: Cases included in this study concludes that, despite the increased risks of pregnancy in woman with epilepsy, with appropriate clinical management with newer drugs, more than 90 percent woman with epilepsy can have successful pregnancies and better neonatal outcome. Moreover because of prepregnancy planning, counselling and optimisation of antiepileptic drug regimens and use of preconception folic acid, pregnancy outcome have become better. A higher teratogenic potential was confirmed for traditional antiepileptic drugs, particularly Valproate. Lower rates of congenital malformations were found for levetiracetam(1.7%) than in association with VPA (6.9%)
Introduction
Pregnancy with epilepsy is indeed high risk pregnancy. About 2.5 million women in Indian suffer from epilepsy, with 52 of them being in the reproductive age group. 1 Epilepsy is the second most common neurological disorder in obstetrics encountered between 0.3% and 0.6% of the patients. Incidence of epilepsy in our hospital is 0.4%. The effect of epilepsy on pregnancy are varied and include the effect of epilepsy itself, like seizures, and the effect of antiepileptic drugs.
Women with epilepsy are advised to continue antiepileptic drugs(AEDs) during pregnancy to reduce maternal and fetal trauma associated with seizures. The goal is optimal seizure control with minimum fetal exposure to AEDs. Prenatal exposure to AEDs may be associated with major congenital malformations, intrauterine growth retardation, dysmorphic syndromes deficits in neurocognitive development. 2 It is proposed that epilepsy should be treated with smallest effective dose of an anticonvulsant drug. The overall risk for major congenital malformatioms is approximately 2.2% for carbamazepine, 3.2% for lamotrizine, 3.7% for phenytoin and 6.2% for valproate. 3 Valproate shows higher risk of congenital malformations as well as adverse behavioral developmental and cognitive outcomes. Also some studies have suggested that polytherapy increases risk of major congenital anomaly from 3.5% to 4%. 4 Nowadays the most https://doi.org/10.18231/j.ijogr.2020.030 2394-2746/© 2020 Innovative Publication, All rights reserved. 136 common preferred antiepileptic drugs are lamotrigine and levetiracetam. Here we are discussing 5 cases of pregnancy with epilepsy on polytherapy and the different components including maternal and perinatal outcome.
Objective
To study the maternal and perinatal outcome in pregnant women with epilepsy on polytherapy.
Materials and Methods
This retrospective observational study was conducted in R.L.Jalappa Hospital Kolar India over a period of 6 months (December 2017 -June 2018). Five pregnant women with epilepsy attending the antenatal clinic were admitted in labour ward in a tertiary care hospital taking two or more antiepileptic drugs were evaluated.
Cases

Case 1
A 27 year old, primigravida, with preterm gestation with RH negative pregnancy and known case of epilepsy since 10 years on 
Case 5
35 years old G2P1L1 reported to our hospital with 35 weeks 6 days gestation. She was a known case of epilepsy since 3 yrs on tab phenobarbiton 60mg OD and tab phynetoin 100mg OD. She had last episode of convulsions at 4 months of amenorrhea. Her anomaly scan revealed no gross anomaly. Patient underwent emergency LSCS in view of fetal distress, patient had a male baby 2.2 kg, with normal apgar score. Postnatally no further episodes of convulsions.
Conclusion
Cases include in this study concludes that, despite the increased risks of pregnancy in woman with epilepsy, with appropriate clinical management and with newer drugs more than 90 percent women with epilepsy hat successful pregnancies and better neonatal outcome. Previous studies showed that monotherapy should be preferred than polytherapy owing to its risk of congenital malformations and low dose of anticonvulsant is preferred to high dose. 5 Since the main goal of pregnancy management is seizure prevention, dose should be increased until seizures are controlled and also a second drug can be added. A higher teratogenic potential was confirmed for traditional antiepileptic drugs, particularly Valproate. Lower rates of congenital malformations were found for tab levetiracetam (1.7%) than in association with VPA(6.9%). 6 In this study inspite of use two or more antiepileptics, no congenital anomalies were detected in anomaly scan. Only one patient had post partum convulsion and 4 out of 5 patients underwent caesarean section. Fetal outcome was also good since no congenital anomalies were detected at birth and babies were born with good apgar score. Moreover because of prepregnancy planning, counselling and optimisation of antiepileptic drug regimens and use of preconception folic acid, pregnancy outcome has become better which is reflected in our study.
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